Health Sciences In The Media

Experts discuss the health impacts of kratom, an unregulated stimulant sold at convenience stores.

Wearing shoes inside your house could put your health at risk, according to a doctor in a viral TikTok post who cites a study, led by Kelly Reynolds, PhD, MSPH, professor and chair of the Department of Community, Environment and Policy in the Mel and Enid Zuckerman College of Public Health, that found bacteria on the outsides of 96% of shoes.

Michael Grandner, PhD, director of the Sleep and Health Research Program at the College of Medicine – Tucson, took part in the White House Office of Public Engagement's Sleep Equity Convening, which focused on sleep as a social justice issue.

Paul M. Gignac, PhD, associate professor in the Department of Cellular and Molecular Medicine at the College of Medicine – Tucson, co-authored a study that mapped neurological pathways that control vision in chickens with detailed 3D models of the connections between the eyes and four regions of the brain.

Affordable Care Act enrollment surged to new highs in Arizona and the nation in 2023 as people shifted away from pandemic-era health coverage and the Biden administration continued to push for the program.

The 2024 Take a Swing at Cancer event on Feb. 20 at the Preserve Golf Club will raise funds for the UArizona Cancer Center.

The Father’s Day Council Tucson honors individuals whose achievements and values enhance the meaning and status of Father’s Day. The program raises funds for Type 1 diabetes research and endowment at Steele Children’s Research Center at the University of Arizona College of Medicine – Tucson.

The story lists the OB-GYN residency program at the College of Medicine – Phoenix as one of the 10 most-searched programs of its type on FREIDA™, the American Medical Association Residency & Fellowship Database®.

According to the Centers for Disease Control and Prevention, suicide rates reached an all-time high in 2022. The 988 Suicide and Crisis Lifeline was implemented to address mental health crises.

Abbott Laboratories received approval from the Food and Drug Administration for the launch of its Liberta Rechargeable Deep Brain Stimulation system, which features remote programming for treating people with movement disorders.